Volunteer takes on mosquito bites for malaria drug trial


Mosquito bites are the only way humans can contract malaria, one of the world's oldest and deadliest diseases.

While it can be treated, there are no vaccines to prevent infection. But the first clinical trial for a vaccine against the most widespread strain, Plasmodium vivax is now under way at the Walter Reed Army Institute for Research.

Volunteers are given varying doses of a protein that stimulates their immune system and are then bitten by infected mosquitoes to see if the inoculation works.

Scientists say it will be at least another week before they have conclusive results. Nick van Gorden is one of the 33 volunteers taking part in the trial.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.